PMC:7029759 / 32390-32544 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"855","span":{"begin":38,"end":42},"obj":"Gene"},{"id":"856","span":{"begin":132,"end":136},"obj":"Gene"},{"id":"868","span":{"begin":14,"end":23},"obj":"Species"},{"id":"869","span":{"begin":24,"end":32},"obj":"Species"}],"attributes":[{"id":"A855","pred":"tao:has_database_id","subj":"855","obj":"Gene:59272"},{"id":"A856","pred":"tao:has_database_id","subj":"856","obj":"Gene:59272"},{"id":"A868","pred":"tao:has_database_id","subj":"868","obj":"Tax:2697049"},{"id":"A869","pred":"tao:has_database_id","subj":"869","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ting treating 2019-nCoV patients with ACE2-Fc will also tolerated. If investigators are still concerned, critical amino acid(s) for ACE2 peptidase activit"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T427","span":{"begin":14,"end":23},"obj":"SP_7"},{"id":"T426","span":{"begin":38,"end":42},"obj":"G_3;PG_10;PR:000003622"},{"id":"T425","span":{"begin":132,"end":136},"obj":"G_3;PG_10;PR:000003622"}],"text":"ting treating 2019-nCoV patients with ACE2-Fc will also tolerated. If investigators are still concerned, critical amino acid(s) for ACE2 peptidase activit"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T209","span":{"begin":114,"end":124},"obj":"Body_part"}],"attributes":[{"id":"A209","pred":"fma_id","subj":"T209","obj":"http://purl.org/sig/ont/fma/fma82739"}],"text":"ting treating 2019-nCoV patients with ACE2-Fc will also tolerated. If investigators are still concerned, critical amino acid(s) for ACE2 peptidase activit"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T337","span":{"begin":43,"end":45},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"ting treating 2019-nCoV patients with ACE2-Fc will also tolerated. If investigators are still concerned, critical amino acid(s) for ACE2 peptidase activit"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T144","span":{"begin":114,"end":124},"obj":"Chemical"},{"id":"T145","span":{"begin":114,"end":119},"obj":"Chemical"},{"id":"T146","span":{"begin":120,"end":124},"obj":"Chemical"}],"attributes":[{"id":"A144","pred":"chebi_id","subj":"T144","obj":"http://purl.obolibrary.org/obo/CHEBI_33709"},{"id":"A145","pred":"chebi_id","subj":"T145","obj":"http://purl.obolibrary.org/obo/CHEBI_46882"},{"id":"A146","pred":"chebi_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"}],"text":"ting treating 2019-nCoV patients with ACE2-Fc will also tolerated. If investigators are still concerned, critical amino acid(s) for ACE2 peptidase activit"}